Cardiovascular aging is associated with a decline in the function of the vascular endothelium. Considerable evidence indicates that age-induced impairment of endothelium-dependent vasodilation results from a reduction in the availability of nitric oxide (NO ), and age-related increases in ROS have been demonstrated to contribute to reduced endothelium-dependent vasodilation in numerous large artery preparations. In contrast, emerging data suggest that ROS may play a compensatory role in endothelial function of the aging microvasculature. The primary goal of this review is to discuss reports in the literature which indicate that ROS function as important signaling molecules in the aging microvasculature. Emphasis is placed upon discussion of the emerging roles of hydrogen peroxide (H 2 O 2 ) and peroxynitrite (ONOO
•)) in the aging microcirculation. Overall, existing data in animal models suggest that maintenance in the balance of ROS is critical to successful microvascular aging. The limited work that has been performed to investigate the role of ROS in human microvascular aging is also discussed, and the need for future investigations of ROS signaling in older humans is considered.Key words: microvasculature, reactive oxygen species, nitric oxide, hydrogen peroxide, peroxynitrite Abbreviations used: cAMP, cyclic adenosine monophosphate; cGMP, cyclic guanosine monophosphate; EDHF, endotheliumderived hyperpolarizing factor; eNOS, endothelial nitric oxide synthase; H 2 O 2 , hydrogen peroxide; HIF-1a, hypoxia-inducible factor-1a; HO, hydroxyl radical; HO-1, heme oxygenase-1; l-NAME, l-nitro-arginine methyl ester; l-NNMA, l-NGmonomethyl arginine; NAD(P)H, nicotinamide adenine dinucleotide phosphate; NO, nitric oxide; NOS, nitric oxide synthase; NQO1, NAD(P)H:quinone reductase 1; Nrf2, nuclear factor (erythroid-derived 2)-related factor-2; O 2 , superoxide; ONOO, peroxynitrite; sGC(b)1, soluble guanylate cyclase (b)1 subunit; SOD, superoxide dismutase.